If this trend holds steady, the sector is on track for an $8.4B year, and may even top 2018's record-breaking annual funding total.
BlueCross BlueShield Venture Partners invests in higi to expand the ecosystem that will personalize population health.
This funding will allow the company to pursue FDA clearance and quickly expand its team for commercial launch.
The company plans to use the funds to continue expanding its customer base and enhancing its data visualizations and advanced analytics.
With this additional funding, the company will extend the capabilities of its platform, as well as expand and commercialize its solutions.
The company will use the funds to expand the reach of its mobile-enabled platform beyond New York City and to also work with in-clinic physical therapists.
The company will use the funds to expand to other chronic conditions, and move to international markets.
The platform is designed to help doctors monitor patients for the early detection of atrial fibrillation, which is the most common cardiac arrhythmia.
The company will use the money to wearables-powered service to reach more private practices across the U.S.
The capital will be used to fund the development of DokChain, blockchain for healthcare, and expand access to PokitDok's API solutions.